Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV001199526 | SCV001162622 | pathogenic | Cone-rod dystrophy | 2020-01-09 | criteria provided, single submitter | research | |
Ce |
RCV001093084 | SCV001249900 | pathogenic | not provided | 2018-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002551709 | SCV003227878 | pathogenic | PRPH2-related disorder | 2022-08-05 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 813081). This variant has not been reported in the literature in individuals affected with PRPH2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp246*) in the PRPH2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRPH2 are known to be pathogenic (PMID: 8111389, 8485575, 8485576, 8675410, 16916875, 17504850, 22863181, 25675413, 26061163, 27365499, 29555955, 33546218). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV004818152 | SCV005069114 | pathogenic | Retinal dystrophy | 2015-01-01 | criteria provided, single submitter | clinical testing |